공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

의약품 의료기기 병용 제품 시장 : 성장, 동향, 예측(2020-2025년)

Drug Device Combination Products Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 03월 상품 코드 925338
페이지 정보 영문
가격
US $ 4,250 ₩ 4,788,000 PDF (Single User License)
US $ 4,750 ₩ 5,352,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 6,760,000 PDF (Site License)
US $ 7,500 ₩ 8,451,000 PDF (Corporate License)


의약품 의료기기 병용 제품 시장 : 성장, 동향, 예측(2020-2025년) Drug Device Combination Products Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 03월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 의약품 의료기기 병용 제품 시장은 주로 당뇨병, 호흡기질환, 암 등의 만성 질환 유병률 증가에 의해 추진되고 있습니다. 또한 고령자 인구 증가와 약물전달 시스템의 기술적 진보에 의해 2020-2025년간 시장 성장이 촉진될 것으로 예측됩니다. 또한 의약품 의료기기 병용 제품의 용도 확대에 의한 새로운 전개에 의해 시장 성장이 기대됩니다. 그러나 엄격한 규제 정책, 제품 리콜 및 몇 가지 의약품 의료기기 병용과 관련된 합병증은 시장 성장을 저해하는 요인이 될 것으로 예상됩니다.

세계의 의약품 의료기기 병용 제품(Drug Device Combination Products) 시장에 대해 조사했으며, 시장 기회와 동향, 성장 촉진요인과 억제요인, 부문별 및 지역별 시장 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 서론

  • 조사 성과
  • 조사 가정
  • 조사 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 성장 촉진요인
    • 새로운 약물전달 시스템의 필요성과 만성 질환 발생률 증가
    • 노년 인구 증가
  • 시장 성장 억제요인
    • 엄격한 정부 정책
    • 제품 리콜과 관련 합병증
  • Porter's Five Forces 분석
    • 신규 참여업체의 위협
    • 바이어/소비자의 협상력
    • 공급업체의 협상력
    • 대체 제품의 위협
    • 경쟁 격화

제5장 시장 세분화

  • 제품별
    • 약물방출스텐트
    • 경피 패치
    • 주입 펌프
    • 약물방출풍선
    • 기타
  • 용도별
    • 심혈관
    • 당뇨병
    • 암치료
    • 기타
  • 최종사용자별
    • 병원
    • 외래 수술 센터
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동 및 아프리카
    • 남미

제6장 경쟁 상황

  • 기업 개요
    • Abbott Laboratories
    • Medtronic Plc
    • Boston Scientific Corp
    • Becton, Dickinson and Company
    • Novartis AG
    • GlaxoSmithKline plc
    • Allergen, Inc.
    • WL Gore & Associates, Inc.
    • Stryker Corporation
    • CareFusion Corporation

제7장 시장 기회 및 향후 동향

KSM 20.05.20

The market is primarily driven by the growing prevalence of chronic diseases such as diabetes, respiratory diseases and cancer. Furthermore, the growing geriatric population and technological advances in drug delivery systems is projected to boost market growth over the forecast period. Moreover, expanding applications of drug device combination products, new developments over the period are expected to bolster the market growth.

However, stringent regulatory policies, product recalls and complications associated with some of the drug device combinations are expected to hamper the market. On the other hand, growing healthcare infrastructure, advances in drug delivery technologies are expected to aid the market growth over the period.

Key Market Trends

Transdermal Patches are Expected to Grow at Notable Rates

  • Transdermal patches are the medicated adhesive patch that is placed on the skin to deliver a specific dose of the drug. Transdermal patches are used in many applications such as pain relief, neurological and others.
  • Drug-eluting stents segment of the market is projected to have a significant growth rate owing to growing cardiovascular diseases coupled with the ageing population. Moreover, the development of new products and recent product launches are expected to boost the segment share.
  • According to the World Health Organization, cardiovascular diseases cause 17.9 million deaths each year. According to the International Diabetes Federation (IDF), in 2017, about 425 million people worldwide were living with diabetes.
  • The increasing adaptation of prefilled insulin pens coupled with the advent of innovative drug combination products expected to boost the market growth over the forecast period.

North America is Projected to Have Significant Market Share

North America is projected to have a significant market share among the regions owing to the adaptation of drug-device combination products coupled with well-established healthcare infrastructure in the region. In addition, new product launches, high R&D investments and the growing prevalence of chronic diseases is expected to boost the regional growth. Moreover, Due to the rising incidence of diseases such as diabetes, neurological pain and cancer in emerging countries of Asia-Pacific are expected to boost the Asia Pacific regional share. Furthermore, companies' interest in expanding into developing economies of Asia coupled with the presence of a large pool of diseased population expected to fuel Asia Pacific market growth rate.

Competitive Landscape

The drug device combination market is moderately fragmented with many market players. Market players focusing on new product developments, collaborations and regional expansion to expand their market share.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Incidence of Chronic Diseases coupled with Need For Novel Drug Delivery Systems
    • 4.2.2 Increase in Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Stringent Government Policies
    • 4.3.2 Product Recalls and Associated Complications
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Products
    • 5.1.1 Drug Eluting Stents
    • 5.1.2 Transdermal Patches
    • 5.1.3 Infusion Pumps
    • 5.1.4 Drug Eluting Balloon
    • 5.1.5 Inhalers
    • 5.1.6 Others
  • 5.2 By Application
    • 5.2.1 Cardiovascular
    • 5.2.2 Diabetes
    • 5.2.3 Cancer Treatment
    • 5.2.4 Respiratory Diseases
    • 5.2.5 Others
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Medtronic Plc
    • 6.1.3 Boston Scientific Corp
    • 6.1.4 Becton, Dickinson and Company
    • 6.1.5 Novartis AG
    • 6.1.6 GlaxoSmithKline plc
    • 6.1.7 Allergen, Inc.
    • 6.1.8 W. L. Gore & Associates, Inc.
    • 6.1.9 Stryker Corporation
    • 6.1.10 Terumo Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q